Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of rare diseases in the United Kingdom and the United States. The company develops Setrusumab, an antibody for the treatment of osteogenesis imperfecta; Alvelestat, an oral small...
6 insider purchases on record · latest filing 2007-10-17.
Insiders have also filed 28 sale transactions at MREO.